Emily Legan

Emily Legan, PhD, is a Technology Specialist at Clark+Elbing LLP since April 2023, following extensive research experience in biochemistry and cell biology. At Emory University Department of Pediatrics from May 2018 to November 2022, Emily conducted dissertation research in the Renhao Li Lab, focusing on the regulation and activation mechanisms of von Willebrand factor. Prior to this, Emily interned at the BloodCenter of Wisconsin, studying clathrin-mediated endocytosis in platelets, and served as a writing tutor at the Norman H. Ott Memorial Writing Center. Emily's academic journey began with an undergraduate research assistant role under Dr. Anita Manogaran at Marquette University, investigating prion formation. Emily holds a PhD in Biochemistry, Cell, and Developmental Biology from Emory University and a BS in Biochemistry and Molecular Biology, graduating magna cum laude from Marquette University.